Comparison Of 5 CP-690,550 Doses Vs. Placebo, For The Treatment Of Rheumatoid Arthritis In Japan
Status:
Completed
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
To evaluate the dose-response relationship of 5 dose of CP-690,550, compared to placebo for
the treatment of signs and symptoms in patients with active RA who failed an adequate trial
of therapy with at least 1 DMARD in a 12-week therapy.